SCHEMBL29646476

SCHEMBL29646476

COc1ccc(-c2nc3c4c(C5CN(C(=O)OC(C)(C)C)C5)cccc4nc(N[C@@H]4CCCCNC4=O)n3n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 3/20 0.38
ALDH1A1 P00352 4/20 0.37
BACE1 P56817 1/20 0.36
HTT P42858 2/20 0.36
KDM4E B2RXH2 3/20 0.35
HPGD P15428 2/20 0.35
MEN1 O00255 1/20 0.35
TSHR P16473 1/20 0.35
CRHBP P24387 1/20 0.35
KMT2A Q03164 1/20 0.35
CRHR2 Q13324 1/20 0.35
HSD17B10 Q99714 1/20 0.35
SYK P43405 3/20 0.34
ZAP70 P43403 2/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
GPR119 Q8TDV5 1/20 0.34
SRC P12931 1/20 0.33
DDB1 Q16531 1/20 0.33
CRBN Q96SW2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22979123 1.00 HPGDS (0.38) HPGDSALDH1A1BACE1HTTKDM4E
SCHEMBL29649029 0.97 HPGDS (0.36) HPGDSALDH1A1BACE1HTTKDM4E
SCHEMBL22979872 0.91 HPGDS (0.40) HPGDSALDH1A1KDM4ESYKZAP70
SCHEMBL29648632 0.89 ALDH1A1 (0.41) HPGDSALDH1A1KDM4ESYKZAP70
SCHEMBL22979361 0.89 ALDH1A1 (0.41) HPGDSALDH1A1KDM4ESYKZAP70
SCHEMBL22988140 0.86 ALDH1A1 (0.39) HPGDSALDH1A1KDM4ESYKZAP70
SCHEMBL29648817 0.86 ALDH1A1 (0.39) HPGDSALDH1A1KDM4ESYKZAP70
SCHEMBL22979750 0.86 ALDH1A1 (0.39) HPGDSALDH1A1KDM4ESYKZAP70
SCHEMBL29648850 0.86 ALDH1A1 (0.39) HPGDSALDH1A1KDM4ESYKZAP70
SCHEMBL22979584 0.85 ALDH1A1 (0.38) HPGDSALDH1A1KDM4ETSHRSYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114466850-B [1,2,4] Triazolo [1,5-C ] quinazolin-5-amine 拜耳股份有限公司 2024-09-10 CN disclosed
US-20230113037-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES BAYER AKTIENGESELLSCHAFT (DE) 2023-04-13 US disclosed
EP-4013508-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES Bayer Aktiengesellschaft (DE) 2022-06-22 EP disclosed
CN-114466850-A [1,2,4] triazolo [1,5-C ] quinazolin-5-amines 拜耳股份有限公司 2022-05-10 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230113037-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES AHR, HRH4, HRH1 HPGDS 517/4885ALDH1A1 597/4885BACE1 3001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.